Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sickle cell disease; An overview of the disease and its systemic effects.

Literature DB >> 29395106

Sickle cell disease; An overview of the disease and its systemic effects.

Sahar Alrayyes¹, Danny Baghdan², Rami Y Haddad³, Anne-Ashley Compton⁴, Sandra Mohama⁵, Reihaneh Goreishi⁶, Nadia Kawar⁷.

Abstract

Mesh：

Year: 2018 PMID： 29395106 DOI： 10.1016/j.disamonth.2017.12.003

Source DB: PubMed Journal: Dis Mon ISSN： 0011-5029 Impact factor: 3.800

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. The National Heart, Lung, and Blood Institute Strategic Vision Implementation for Health Equity Research.

Authors: George A Mensah; Catherine M Stoney; Michelle M Freemer; Sharon Smith; Michael M Engelgau; W Keith Hoots; James P Kiley; David C Goff
Journal: Ethn Dis Date: 2019-02-21 Impact factor: 1.847

2. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.

Authors: Jason R Hodges; Shannon M Phillips; Sarah Norell; Chinonyelum Nwosu; Hamda Khan; Lingzi Luo; Sherif M Badawy; Allison King; Paula Tanabe; Marsha Treadwell; Lucia Rojas Smith; Cecelia Calhoun; Jane S Hankins; Jerlym Porter
Journal: Blood Adv Date: 2020-09-22

3. Oral manifestations of sickle cell disease.

Authors: M Chekroun; H Chérifi; B Fournier; F Gaultier; I-Y Sitbon; F Côme Ferré; B Gogly
Journal: Br Dent J Date: 2019-01-11 Impact factor: 1.626

Review 4. Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

Authors: Piyusha P Pagare; Aref Rastegar; Osheiza Abdulmalik; Abdelsattar M Omar; Yan Zhang; Andrew Fleischman; Martin K Safo
Journal: Expert Opin Ther Pat Date: 2021-11-01 Impact factor: 6.714

5. Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.

Authors: Marie Gerardin; Morgane Rousselet; Marie-Laure Couec; Agathe Masseau; Marylène Guerlais; Nicolas Authier; Sylvie Deheul; Anne Roussin; Joelle Micallef; Samira Djezzar; Fanny Feuillet; Pascale Jolliet; Caroline Victorri-Vigneau
Journal: PLoS One Date: 2021-03-18 Impact factor: 3.240

Sickle cell disease; An overview of the disease and its systemic effects.

1. The National Heart, Lung, and Blood Institute Strategic Vision Implementation for Health Equity Research.

2. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.

3. Oral manifestations of sickle cell disease.

Review 4. Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

5. Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.

6. Presentation, management, and outcomes of COVID-19 in patients with sickle cell disease.

Review 7. Bone fragility in patients affected by congenital diseases non skeletal in origin.

Review 8. A Meta-Analysis on the Seroprevalence of Parvovirus B19 among Patients with Sickle Cell Disease.

9. Predictors of dental complications post-dental treatment in patients with sickle cell disease.